NCT00871598View on ClinicalTrials.gov

BTT1023 in Psoriasis

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Plaque Psoriasis
Interventions
DRUG

BTT1023

intravenous, three infusions over three weeks

DRUG

Placebo

intravenous, three infusions over three weeks

DRUG

BTT1023

Test challenge

Trial Locations (5)

12627

Biotie investigational site, Berlin

14050

Biotie investigational site, Berlin

01067

Biotie investigational site, Dresden

04103

Biotie investigational site, Leipzig

02826

Biotie Investigational Site, Görlitz

Sponsors
All Listed Sponsors
lead

Biotie Therapies Corp.

INDUSTRY